Results 1 to 10 of about 545,595 (268)

Data-mining of potential antitubercular activities from molecular ingredients of traditional Chinese medicines [PDF]

open access: yesPeerJ, 2014
Background. Traditional Chinese medicine encompasses a well established alternate system of medicine based on a broad range of herbal formulations and is practiced extensively in the region for the treatment of a wide variety of diseases. In recent years,
Salma Jamal   +2 more
doaj   +2 more sources

Identification of the first highly selective inhibitor of human lactate dehydrogenase B

open access: yesScientific Reports, 2021
Lactate dehydrogenase (LDH) catalyses the conversion of pyruvate to lactate and NADH to NAD+; it has two isoforms, LDHA and LDHB. LDHA is a promising target for cancer therapy, whereas LDHB is necessary for basal autophagy and cancer cell proliferation ...
Sachio Shibata   +8 more
doaj   +1 more source

UnCorrupt SMILES: a novel approach to de novo design

open access: yesJournal of Cheminformatics, 2023
Generative deep learning models have emerged as a powerful approach for de novo drug design as they aid researchers in finding new molecules with desired properties.
Linde Schoenmaker   +3 more
doaj   +1 more source

A novel orally active HDAC6 inhibitor T-518 shows a therapeutic potential for Alzheimer’s disease and tauopathy in mice

open access: yesScientific Reports, 2021
Accumulation of tau protein is a key pathology of age-related neurodegenerative diseases such as Alzheimer's disease and progressive supranuclear palsy. Those diseases are collectively termed tauopathies.
Tomohiro Onishi   +8 more
doaj   +1 more source

Full-length in meso structure and mechanism of rat kynurenine 3-monooxygenase inhibition

open access: yesCommunications Biology, 2021
Mimasu et al. report a rat full-length structure of kynurenine 3-monooxygenase (KMO) in its membrane-embedded form, complexed with two inhibitors. They find that the dimeric interface of KMO is critical for its activity. This study provides insights into
Shinya Mimasu   +10 more
doaj   +1 more source

An engineered tetra-valent antibody fully activates the Tie2 receptor with comparable potency to its natural ligand angiopoietin-1

open access: yesScientific Reports, 2021
Activation of the tyrosine kinase with Ig and epidermal growth factor homology domain 2 (Tie2) receptor by angiopoietin-1 (Ang1) is critical for vascular stabilization: it promotes survival signal transduction via auto-phosphorylation and reduces ...
Yukari Koya   +4 more
doaj   +1 more source

Fibronectin extra domain A as a drug delivery targeting epitope for rheumatoid arthritis

open access: yesAdvances in Rheumatology, 2022
Objectives To assess the ability of monoclonal antibodies (mAbs) specific for fibronectin extra-domain A (FnEDA) to target diseased tissues of mouse collagen induced arthritis (mCIA) models.
Victor Z. Sun   +13 more
doaj   +1 more source

Conversion of Aquaculture Waste into Biomedical Wealth: Chitin and Chitosan Journey

open access: yesAdvances in Materials Science and Engineering, 2022
Biowaste originating from aquaculture sector represents a potential feedstock to produce value-added substances and materials like chitin and chitosan. They are the long chain polymers of N-acetylglucosamine polymers with huge industrial and biomedical ...
Jerrine Joseph   +8 more
doaj   +1 more source

Angiopoietin-2 impairs collateral artery growth associated with the suppression of the infiltration of macrophages in mouse hindlimb ischaemia

open access: yesJournal of Translational Medicine, 2016
Background Angiopoietin-2 (Ang-2), a ligand of the Tie-2 receptor, plays an important role in maintaining endothelial cells and in destabilizing blood vessels. Collateral artery growth (arteriogenesis) is a key adaptive response to arterial occlusion. It
Xiaoyong Tan   +11 more
doaj   +1 more source

Cheminformatics Models for Inhibitors of Schistosoma mansoni Thioredoxin Glutathione Reductase

open access: yesThe Scientific World Journal, 2014
Schistosomiasis is a neglected tropical disease caused by a parasite Schistosoma mansoni and affects over 200 million annually. There is an urgent need to discover novel therapeutic options to control the disease with the recent emergence of drug ...
Sonam Gaba   +3 more
doaj   +1 more source

Home - About - Disclaimer - Privacy